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Indications and Contraindications

Peritoneovenous Shunt History

Indications

Relative
Absolute
Contraindications Contraindications

Intractable malignant or
cirrhotic ascites not
responding to medical
treatment and large
volume paracentesis

Compensated congestive
heart failure

Blood ascites

Life expectancy of more
than 3 months

Loculated ascites or
peritoneal adhesions

Renal failure if the patient
is not on dialysis

Chylous ascites

Peritoneal disease, i.e.,
peritoneal mesothelioma

History of varicose vein
bleeding

None of the
contraindication exists

Massive pleural effusion

Grade ¾ esophageal
varices

Varices with no history of
bleeding

CHF or advanced cardiac
disease

Portal hypertension

Respiratory failure with
pulmonary edema

Why the Denver Shunt?

Positive cytology of the
ascites fluid

Liver failure (T Bili > 2.0
mg/dL)

Ascites is the retention of fluid in the peritoneal cavity
and is one of the most frequent complications of liver
cirrhosis (failure), occurring in approximately 50%
of patients with severe liver disease (Caly et al, 2017).
There are many treatment methods for ascites, some of
which include multiple paracentesis, a special diet,
the transjugular intrahepatic portosystemic shunt
procedure, as well as peritoneovenous shunts. (Caly et

Simultaneous
gastrointestinal surgery

Coagulation disorders
(Low platelet counts < 50 x
10^9 or high INR > 2.0

Peritoneovenous shunts have been used to treat ascites
with Interventional Radiology (IR), for over 50
years. Being the first in a line of shunts, the Hyde
shunt was used from 1964-1974. It was improved
and renamed the LeVeen shunt, being used from
1974-1979. The LeVeen shunt was then modified,
creating the popular Denver shunt in 1979. (Ilda, et al,
2017) Peritoneovenous shunts have been used for the
same purpose since first developed; treating ascites
by pumping the fluid within the peritoneal cavity into
the superior vena cava. This allows the body to
naturally retain the nutrients within this fluid while
also expelling it from the peritoneal cavity.

al, 2017)

The Denver shunt is available in two sizes. The 11.5
French shunt is used when the saphenous or
subclavian veins are used. The 15.5 French shunt is
used with the internal jugular vein is used.
The Denver shunt works by having one end of the
catheter in the peritoneal cavity and the other leading
to the inferior vena cava. There is then a one way
valve within a subcutaneous pump that is placed
anterior to a rib so it can be compressed to move the
fluid (Farrell & Dennison, 2016, p336). The subcutaneous
pump is either a single or double valve, the single
valve provides a faster flow rate than the double
valve.; though the double valve is more efficient in
preventing reflux. The double valve, 15.5 French
shunt is the most commonly used. (Yarmohammadi &
Fenestrated end
(peritoneal end)

(Yarmohammadi & Getrajdman, 2017)

The procedure is performed with the patient supine and
under conscious sedation using local anesthesia.
Starting with lidocaine, an incision is made above the
lowest rib on the right, followed by another incision 810 cm below the right hypochondrium. This second
incision is for access into the peritoneal cavity and is
determined using sonography. The subcutaneous pocket
is created on the lowest right rib. The peritoneal cavity
is drained of ascites to almost completion, leaving
enough to prime the shunt. If too much fluid is drained,
saline can be used to prime the shunt. The Fenestrated
side of the Denver shunt is inserted into the peritoneum
using a peel-away sheath. Venous access of the right
subclavian, saphenous, or jugular vein is achieved and
the catheter is tunneled from the subcutaneous pocket
to whichever vein is used. Fluoroscopy is used to
ensure correct length and position. (Ilda et all, 2017) often
times an antibiotic is also given to the patient to prevent
any infection.

• The most severe complications include pulmonary
embolism and central venous thrombosis. Both of
these complications can be life threatening, though
some can be treated effectively.
• Disseminated intravascular coagulation or DIC is a
complication that is often most discussed in relation
to the Denver shunt. DIC occurs when the ascites
alters the coagulation in the blood, causing either
hyperactive or underactive clotting throughout the
blood stream. (Tamagawa et al, 2020)
• Occlusion of the shunt happens often, being the most
common complication through various studies (White
et al, 2011). The use of thrombolytic therapy or the
replacement of the shunt may be the only two
solution for occlusion (Tamagawa et al, 2020). The 15.5
French Denver shunt is less likely to occlude
(Yarmohammadi & Getrajdman, 2017) .

Poor performance status
Anasarca or
hypoalbuminemia (serum
albumin < 2.5 g/dL)

A patient is considered a good candidate if; they meet
the indications in the chart above, none of the
contraindications are present, and have healthy
cardiac and respiratory functions. (Ilia et al, 2017)

(White et al, 2011)

Successes and Removal of Denver Shunt

Ascites

Compression
chamber of shunt

In the left image the arrow is showing the tip of the catheter proximal to the
right atrium. In the middle image the arrow is showing the compression
chamber or pump. In the right image the arrow is demonstrating the end of the
catheter. (Yarmohammadi & Getrajdman, 2017)

Post-op and Follow up
CT imaging showing ascites within the peritoneal cavity before and
after the placement of the Denver shunt. (Won et al, 2008)

Pre-op
Patients lab values are examined at different intervals
prior to the procedure. These lab values consist of
blood urea nitrogen (BUN), albumin levels, platelet
count, bilirubin levels, creatinine levels, lymphocyte
count, cholesterol levels, exedra (Iida et al, 2017). Lab
values are taken at 3 weeks preop, one week preop,
48 hours preop, and finally at 12 hours preop. This is
to ensure the patient is in good health and remains in
good health prior to the procedure. It also creates a
baseline for these values that can be compared to
after the procedure. The patient has to fast prior to
the procedure due to the use of conscious sedation.
(Yarmohammadi et al, 2017)

(White et al, 2011)

Possible complications

Evidence of nonsterile
ascites (from bile leak or
urine leak)

(Yarmohammadi & Getrajdman, 2017)

How it Works…

Getrajdman, 2017)

Peritonitis or history of
spontaneous bacterial
peritonitis

Placement

Patients will often be admitted after the procedure for a
short time, this is to ensure that no life threatening
complications present. The patient is told to compress
the pump 20 times, twice a day in the supine position
(Yarmohammadi et al, 2017). If no signs of complications
present the patient will be discharged 72 hrs after the
completion of the procedure. Within these 72 hours the
patient’s lab values are checked at 12 hours, 24 hours,
48 hours, and finally at 72 hours. The patient’s lab
values are then checked again one week and one month
after the procedure. Follow-up CT imaging is also
performed every 3 months to ensure the shunt is still in
the correct position without any visual complications,
this is done at least twice and then as needed. Patients
are informed of signs and symptoms to watch for and to
contact the IR department immediately if they believe
something is wrong with the shunt. (Yarmohammadi et al,
2017)

The Denver shunt has been known to be successful in
many ascites patients. Due to the shunt being placed
subcutaneously, the patient is free to shower, swim,
and perform daily activates once the incisions have
healed. Many patients need this shunt for many years
to manage their ascites, though “if imaging can
confirm the resolution of ascites the shunt can be
removed” (Yarmohammadi et al, 2017). The removal of the
shunt is fairly easy with a minimal recovery time.
(Yarmohammadi et al, 2017)

Conclusion
The findings of this research conclude that the Denver
shunt, when used on patients who meet the correct
criteria, is effective in the treatment for ascites. As
scientists continue to research, there is new
technology that builds off of the Denver shunt.
Instead of pumping the ascites fluid into the blood
stream, it is drained into the bladder. This shunt is
still experimental, though may be the next step of
improvement when regarding the treatment of ascites
using peritoneal shunts. (Jain et al, 2019) IR has used the
Denver shunts successfully since 1979, it continues
to bring patients relief of their ascites and give them
hope of an ascites free future.
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